Oculocerebral hypopigmentation syndrome type Preus

Also Known As:

Cross syndrome; Kramer Syndrome; Oculocerebral Hypopigmentation Syndrome of Preus; Oculocerebral syndrome with hypopigmentation

Networked: 6 relevant articles (2 outcomes, 2 trials/studies)

Relationship Network

Disease Context: Research Results

Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
- Congenital Abnormalities: 25723
  - Multiple Abnormalities: 211
    - Oculocerebral hypopigmentation syndrome type Preus: 6
  - Musculoskeletal Abnormalities: 43
    - Craniofacial Abnormalities: 203
      - Oculocerebral hypopigmentation syndrome type Preus: 6
Skin and Connective Tissue Diseases
- Skin Diseases: 13127
  - Pigmentation Disorders: 149
    - Oculocerebral hypopigmentation syndrome type Preus: 6
Signs and Symptoms Pathological Conditions
- Pathologic Processes: 10023
  - Pigmentation Disorders: 149
    - Oculocerebral hypopigmentation syndrome type Preus: 6
Musculoskeletal Diseases: 719
- Musculoskeletal Abnormalities: 43
  - Craniofacial Abnormalities: 203
    - Oculocerebral hypopigmentation syndrome type Preus: 6

Related Diseases

1.	Pain (Aches)
2.	Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome)
3.	Chronic Hepatitis C
4.	Neck Pain (Cervicalgia)
5.	Piebaldism (Partial Albinism)

Experts

1.	Barulin, A E: 1 article (01/2021)
2.	Kalinchenko, B M: 1 article (01/2021)
3.	Kurushina, O V: 1 article (01/2021)
4.	Ain, Qurat -Ul-: 1 article (03/2020)
5.	Gillani, Syeda Nida: 1 article (03/2020)
6.	Masood, Tahir: 1 article (03/2020)
7.	Rehman, Shakil Ur: 1 article (03/2020)
8.	Klusek, Jessica: 1 article (01/2015)
9.	Losh, Molly: 1 article (01/2015)
10.	Roberts, Jane E: 1 article (01/2015)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Oculocerebral hypopigmentation syndrome type Preus:

1.	TolperisoneIBA 01/01/2021 - "To evaluate the efficacy of the drug Tolperisone (Calmirex) in patients with inferior cross syndrome against the background of standard therapy. "
2.	Biomarkers (Surrogate Marker)IBA 01/01/2015 - "This article adopts a cross-syndrome biomarker approach to evaluate potentially overlapping profiles of cardiac arousal dysregulation (and broader autonomic dysfunction) in autism and FXS. "
3.	Monophenol Monooxygenase (Tyrosinase)IBA 01/01/1979 - "There are seven forms of oculo-cutaneous albinism, which are all autosomal recessive: three are tyrosinase-negative (complete oculo-cutaneous albinism, Amish albinism, Hermansky-Pudlak syndrome) and four are tyrosinase-positive (incomplete oculo-cutaneous albinism, Chediak-Higashi syndrome, Cross syndrome, Bergsma's albinism). "
4.	Prednisolone (Predate)FDA LinkGeneric 01/01/2013 - "The most appropriate combinations and doses of prednisolone (budesonid), azathioprine and ursodesoxycholic acid, recommended for treatment of various options of cross-syndrome, as well as medical tactics in view of the conjunction of AIH and chronic hepatitis C, have been considered."
5.	Azathioprine (Imuran)FDA LinkGeneric 01/01/2013 - "The most appropriate combinations and doses of prednisolone (budesonid), azathioprine and ursodesoxycholic acid, recommended for treatment of various options of cross-syndrome, as well as medical tactics in view of the conjunction of AIH and chronic hepatitis C, have been considered."
6.	AcidsIBA 01/01/2013 - "The most appropriate combinations and doses of prednisolone (budesonid), azathioprine and ursodesoxycholic acid, recommended for treatment of various options of cross-syndrome, as well as medical tactics in view of the conjunction of AIH and chronic hepatitis C, have been considered."

Therapies and Procedures

1.	Relaxation Therapy (Relaxation Technique) 10/01/2022 - "And, the second objective of the study was to compare the effect of myofascial rollers and post-isometric relaxation techniques in upper cross syndrome. " 10/01/2022 - "Measuring the Efficacy of Myofascial Rollers and Post-isometric Relaxation Technique in Relieving Pain Intensity and Postural Deviation Using Plumb Line Assessment for the Treatment of Upper Cross Syndrome in Dental Undergraduate (UG) Students."
2.	Therapeutics 01/01/2021 - "To evaluate the efficacy of the drug Tolperisone (Calmirex) in patients with inferior cross syndrome against the background of standard therapy. "
3.	Muscle Stretching Exercises (Stretching, Static) 03/01/2020 - "Effects of eccentric muscle energy technique versus static stretching exercises in the management of cervical dysfunction in upper cross syndrome: a randomized control trial." 03/01/2020 - "To compare the effects of eccentric muscle energy technique versus static stretching exercises combined with cervical segmental mobilisation in the management of upper cross syndrome in patients having neck pain. "